Certified by Founder Lodge
DotBio
Singapore - Singapore
START UP
1 Disclosed Funding Rounds $5,600,000
0 Participating Investments
-
Founded date
2018
-
Operating Status
Active
-
Last Funding Type
Seed
-
Company Type
For Profit
- Website
- Contact
- Social Links
DotBio is focused on the development of novel immuno-oncology drugs based on humanized domain antibodies, its proprietary DotBody technology. DotBodies are domain therapeutic antibodies which
| Date | Round | Raised | Participating Investors |
|---|---|---|---|
| August, 07 ,2023 | Pre Series A | $5,600,000 |
Carmot Therapeutics, Inc.
Ozette Technologies
NAPIGEN, INC.
TrueBinding
Loopworm
HexemBio | $10,400,000 | (Apr 9, 2026)
Trent AI | $13,000,000 | (Apr 9, 2026)
E2 - Endovascular Engineering | $80,000,000 | (Apr 9, 2026)
GoSats - The simplest onramp to Digital Assets in India | $5,000,000 | (Apr 9, 2026)
Aria Networks, Inc. | $125,000,000 | (Apr 9, 2026)
